Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1216858C details enzymatic synthesis of CNS drug intermediates. Offers high optical purity and streamlined manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN1269950C details a novel biotechnological process for preparing amides using Amycolatopsis and Rhodococcus strains, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1220695A details a microbial process for chiral aminoalcohols, offering a scalable alternative to chemical synthesis for carbocyclic nucleosides.
Novel synthesis method for 4,4'-dibromodiphenyl ether ensures high purity and yield. Cost-effective supply chain solution for polymer and pharma intermediates.
Patent CN102993024B reveals a safer sulfonation-methylation route for N,N'-dimethyl cyclohexanediamine, offering high purity >98% and significant cost reduction in fine chemical manufacturing.
Patent CN1916164A reveals high-yield hydantoinase method. Reduces cost in API manufacturing. Reliable pharmaceutical intermediate supplier for D-amino acids.
Patent CN1224697C reveals a novel microbial process for high-purity aminoalcohols, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Novel hydrolysis method improves yield and reduces waste for agrochemical intermediate manufacturing supply chain efficiency and significant cost reduction.
Novel aqueous process for cephalosporin intermediate reduces cost and pollution while ensuring high purity for reliable supply chains.
Advanced solvent-free synthesis of P-Methylsulfonylbenzaldehyde via patent CN103058899A. High yield, eco-friendly process for reliable pharmaceutical intermediate supply chains.
Novel hydrolysis method ensures high-purity reference standards for quality control in dabigatran etexilate manufacturing supply chains.
Patent CN102070581B details a catalyst-free hydrolysis for dronedarone intermediates, offering cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN103159672A details a novel tropicamide preparation using phenyl ethyl malonate, offering cost reduction in pharmaceutical manufacturing and improved supply chain reliability.
Patent CN103304615B reveals high-yield cortisone preparation. Enhances supply chain stability and cost efficiency for global pharmaceutical intermediates manufacturing.
Novel patent CN104557561B offers safe high-yield route for pramiracetam intermediate ensuring cost reduction and supply stability for global buyers.
Patent CN1405143A reveals high-purity 3-nitro phthalic acid synthesis. Offers cost reduction and supply chain reliability for fine chemical intermediates manufacturing.
Patent CN104592254A details enhanced everolimus synthesis yielding higher purity and stability. This method offers supply chain reliability and cost efficiency for pharmaceutical manufacturing.
Novel diazotization-hydrolysis route for high-purity intermediates. Reduces waste and cost for fluorescent whitener production via scalable chemistry.
Patent CN102277322A details a green enzymatic route for IDA production, offering lower costs and reduced waste compared to traditional chemical hydrolysis methods.
Patent CN102277322A details a novel enzymatic route for Iminodiacetic Acid (IDA) synthesis, offering significant waste reduction and milder reaction conditions compared to traditional chemical hydrolysis methods.